Concepedia

Honglin Hu

HH

20

Publications

599

Citations

16

H-Index

2009

Active since

Affiliations

Nanchang University(Current)

Second Affiliated Hospital of Nanchang University

University of Electronic Science and Technology of China

First Affiliated Hospital of Nanchang University

Université Paris Cité

Honglin Hu is an author at Nanchang University specializing in medicine, cell biology, and oxidative stress.

ORCID

Top concepts

Publications per year

2009–2024

20

Publications

20

MicroRNA-21 Attenuates Renal Ischemia Reperfusion Injury via Targeting Caspase Signaling in Mice

Honglin Hu, Wei Jiang, Xiaoqing Xi et al. · American Journal of Nephrology · 2014 · 61 citations

FAT10 promotes the progression of bladder cancer by upregulating HK2 through the EGFR/AKT pathway

Yan Zou, Yunyan Du, Cheng Cheng et al. · Experimental Cell Research · 2020 · 51 citations

, , +8

Pioglitazone protects tubular cells against hypoxia/reoxygenation injury through enhancing autophagy via AMPK-mTOR signaling pathway

Xiaoqing Xi, Cong Zou, Zhenfeng Ye et al. · European Journal of Pharmacology · 2019 · 46 citations

, , +11

Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity

Cong Zou, Honglin Hu, Xiaoqing Xi et al. · Journal of Surgical Research · 2013 · 45 citations

, , +9

Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy Pathway

Wenlin Chen, Xiaoqing Xi, Shuangyang Zhang et al. · Frontiers in Pharmacology · 2018 · 43 citations · Full text

Rows per page

1–5 of 20